353
Views
9
CrossRef citations to date
0
Altmetric
Review

Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritis

&
Pages 1313-1322 | Received 14 Apr 2019, Accepted 28 Oct 2019, Published online: 10 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Elena Baldissera & Lorenzo Dagna. (2020) Current treatment options and safety considerations when treating adult-onset Still’s disease. Expert Opinion on Drug Safety 19:12, pages 1549-1558.
Read now

Articles from other publishers (8)

Wenliang Dong, Xiaowen Hu, Caiying Wu, Gengchen Wang, Yi Fang, Luwen Shi & Xiaoyan Nie. (2023) Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 63, pages 152302.
Crossref
Nedim Kaban & Halil Harman. (2023) Paradigm guiding to tapering or discontinuation of biologic and targeted synthetic disease‐modifying antirheumatic drugs in the treatment of patients with rheumatoid arthritis: Results from a local prospective study . International Journal of Rheumatic Diseases 26:4, pages 689-698.
Crossref
Yoshiya Tanaka, Ayako Yamaguchi, Toshiaki Miyamoto, Kazuhide Tanimura, Hideyuki Iwai, Yuko Kaneko, Tsutomu Takeuchi, Koichi Amano, Naoki Iwamoto, Atsushi Kawakami, Miho Murakami, Norihiro Nishimoto, Tatsuya Atsumi, Takayuki Sumida, Koichiro Ohmura, Tsuneyo Mimori, Hisashi Yamanaka, Keishi Fujio, Yoshihisa Fujino, Kazuyoshi Saito, Kazuhisa Nakano, Shintaro Hirata & Shingo Nakayamada. (2022) Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study. Rheumatology 61:11, pages 4273-4285.
Crossref
Shunsuke Mori, Akitomo Okada, Tomohiro Koga & Yukitaka Ueki. (2022) Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study. PLOS ONE 17:6, pages e0270391.
Crossref
Chao-Jun Hu, Li Zhang, Shuang Zhou, Nan Jiang, Jiu-Liang Zhao, Qian Wang, Xin-Ping Tian & Xiao-Feng Zeng. (2021) Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Le H. Hua. (2021) Treating MS After 50: the Role of Age in Therapeutic Decision-Making. Current Treatment Options in Neurology 23:3.
Crossref
Andrea Di Matteo, Kulveer Mankia, Masayuki Azukizawa & Richard J Wakefield. (2020) The Role of Musculoskeletal Ultrasound in the Rheumatoid Arthritis Continuum. Current Rheumatology Reports 22:8.
Crossref
Kulveer Mankia, Andrea Di Matteo & Paul Emery. (2020) Prevention and cure: The major unmet needs in the management of rheumatoid arthritis. Journal of Autoimmunity 110, pages 102399.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.